At day 10 post-cGN induction, mice that received eIF2α-S51D-transduced CD4+ T cells showed a milder renal disease phenotype, as assessed by glomerular crescent scoring and albuminuria measurement, compared to mice that received eIF2α S51A-transduced CD4+ T cells (Fig. 4f). Here, EIF2A is linked to kidney disorder.